LWM
ASXC

Laidlaw Wealth Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Laidlaw Wealth Management’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-140,000
Closed -$259K – 423
2021
Q3 		$259K Buy
140,000
+105,000
+300% +$236K 0.07% 202
2021
Q2 		$111K Buy
+35,000
New +$87.5K 0.03% 260

Other funds holding ASXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Laidlaw Wealth Management's ASXC Position: Q4 2021 in Review

Laidlaw Wealth Management sold out of Asensus Surgical, Inc. (ASXC) in Q4 2021, closing a stake of 140,000 shares — an estimated $259K sold.

Laidlaw Wealth Management first reported a position in ASXC in Q2 2021 and held it in 2 quarters. The position peaked at $259K in Q3 2021. 114 funds tracked by Wall St. Rank hold ASXC as of Q4 2021.

  • Laidlaw Wealth Management reported no remaining Asensus Surgical, Inc. position as of Q4 2021 after selling out during the quarter.
  • Laidlaw Wealth Management sold 140,000 Asensus Surgical, Inc. shares in Q4 2021, an estimated $259K.
  • Laidlaw Wealth Management first reported a position in Asensus Surgical, Inc. in Q2 2021 and held it in 2 quarters.
  • Laidlaw Wealth Management's Asensus Surgical, Inc. position peaked at $259K in Q3 2021.
  • 114 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2021.

Based on Laidlaw Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.